Comparing transcutaneous and arterial CO2 monitoring during jet ventilation for percutaneous liver tumor ablation
Official title: Transcutaneous Versus Arterial Carbon Dioxide Monitoring During Jet Ventilation
Run by Sahlgrenska University Hospital · NCT07211763 · Data updated 2026-11-12
This project will test whether skin-based (transcutaneous) CO2 monitors give the same readings as arterial blood CO2 in adults having jet ventilation during percutaneous liver tumor ablation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Sahlgrenska University Hospital Academic / other |
| Locations | 1 site (Gothenburg) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | June 2026 |
| Study ends | July 2026 |
| Registry record updated | October 8, 2025 |
| Trial ID | NCT07211763 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults scheduled for percutaneous radiofrequency liver tumor ablation who require jet ventilation and can give informed consent are the intended participants.
✕Probably not a fit
Patients not receiving jet ventilation, minors, or those with conditions that make jet ventilation unsafe would not be eligible and would not benefit from this comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
During percutaneous radiofrequency ablation of liver tumors, high-frequency jet ventilation is used to reduce diaphragm movement but prevents standard end-tidal CO2 monitoring. At this single center, patients receive both transcutaneous CO2 monitoring and arterial blood gas sampling as part of routine care, and consenting patients will have those values collected prospectively. The collected paired measurements will be compared using repeat-measures Bland–Altman analysis to quantify agreement and any systematic differences. All patients are managed according to the usual preoperative and intraoperative protocols and participation only involves allowing use of their monitoring data for analysis.
Why it matters
Potential benefit: If transcutaneous monitoring reliably matches arterial CO2, patients could avoid some invasive blood sampling and clinicians would have a noninvasive way to track ventilation during jet ventilation.
How similar studies have gone: Prior work outside jet ventilation has shown reasonable agreement between transcutaneous CO2 and arterial CO2 in other ventilation settings, but data specifically during high-frequency jet ventilation are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult patients undergoing percutaneous RF liver tumour ablation requiring jet ventilation Exclusion Criteria: * disease or condition. not compatible with jet ventilation
Where it's running
-
Sahlgrenska University Hospital
Gothenburg, Sweden Recruiting
Study contacts
- Principal investigator: Fredrik Olsen, MD PhD — Sahlgrenska University Hospital
- Study coordinator: Fredrik Olsen, MD PhD
- Email: fredrik.olsen@vgregion.se
- Phone: +46 313428169
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Combined multimodal tumor therapy system for liver cancer
Aims to test a multimodal tumor treatment that combines thermal ablation with immune-based approaches for adults with primary or metastatic liver cancer who can’t have surgery.
-
Assessing lung recruitment in preterm infants using echocardiography and ultrasound
This study tests if a special breathing treatment can help preterm infants with breathing problems and compares using ultrasound to check their lungs instead of regular x-rays.
-
High-frequency oscillatory ventilation versus conventional mechanical ventilation for very preterm infants with perinatal ARDS
This trial will test whether high-frequency oscillatory ventilation helps very preterm infants with perinatal ARDS breathe better and reduce lung complications compared with standard mechanical ventilation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.